Business description
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy.
Management board & Supervisory board
| CEO |
| Carsten Hellmann |
| Management board |
| Claus Steensen Sølje, Søren Niegel, Henriette Mersebach |
| Supervisory board |
| Anders Hedegaard, Lene Skole, Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark, Alan Main, Katja Barnkob, Nanna Carlson, Lise Lund Mærkedahl, Johan Smedsrud |
Company data
| Name: |
ALK-Abelló A/S |
| Address: |
Boge Alle 6-8,Horsholm 2970 |
| Phone: |
(+45) 4574 7576 |
| Fax: |
(+45) 4574 8690 |
| E-mail: |
reception@alk-abello.com
|
| Internet: |
www.alk.net |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
- |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
Per Plotnikof |
| IR phone: |
+45 4574 7527 |
| IR Fax: |
- |
| IR e-mail: |
ppidk@alk.net
|
